Tirzepatide, a novel medication, is generating considerable buzz within the scientific community. It functions differently from common diabetes therapies , targeting multiple receptors involved in glucose regulation and appetite . Initial research have demonstrated impressive efficacy in reducing blood sugar in individuals with adult-onset diabetes